Skin Diseases, Papulosquamous  >>  itacitinib (INCB039110)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
itacitinib (INCB039110) / Incyte
NCT01634087: A Study of Escalating Doses of Itacitinib Administered Orally in Patients With Plaque Psoriasis

Checkmark For psoriasis at European Academy of Dermatology and Venereology
Oct 2013 - Oct 2013: For psoriasis at European Academy of Dermatology and Venereology
Checkmark Psoriasis
Oct 2013 - Oct 2013: Psoriasis
Completed
2
50
Canada, US
Itacitinib, INCB039110, Placebo
Incyte Corporation
Plaque Psoriasis
01/13
02/13

Download Options